PubMed ID: 41937961
Author(s): Richey A, Sattarova V, Kopplin LJ, Armbrust KR. Update on Therapy for Non-Infectious Scleritis. Clin Ophthalmol. 2026 Mar 30;20:563490. doi: 10.2147/OPTH.S563490. eCollection 2026. PMID 41937961
Journal: Clinical Ophthalmology (Auckland, N.Z.), Volume 20, 2026
Non-infectious scleritis is a potentially vision threatening inflammatory disease which often requires long-term treatment. The general approach to management consists of a thorough systemic workup and subsequent selection of the most appropriate therapeutic agent(s) for inflammatory control. This article reviews current and emerging therapies for scleritis treatment, including topical agents, systemic non-steroidal anti-inflammatory drugs and corticosteroids, conventional immunomodulatory therapies, and biologics.
© 2026 Richey et al.